Isotopia Molecular Imaging

Petach Tikva, 
  • Booth: 163

Isotopia aspired to be the world leader and innovative company in nuclear medicine by providing meaningful medical care for patients globally.

Isotopia is a Radio Pharmaceutical Company established in 2006. 
Isotopia was founded by a highly trained group of senior professionals, experienced in all aspects of radio-pharmaceutical operations, in collaboration with a group of Canadian investors.

Isotopia’s experienced and highly skilled team, together with its Radio-Pharmaceutical Company and cyclotron facility, provide a sound platform for successful commercial activities, research and development initiatives.

Isotopia operates a PETtrace Cyclotron (GE Healthcare), supplying both PET and SPECT tracers, 18F-labeled products, 177-Lu treatments for prostate cancer and neuroendocrine tumors, cold kit for 68-Ga-PSMA-11 synthesis, manufactured under strict Quality Control.

Brands: isoPROtrace11® - PSMA Coldkit Lu-177 c.a. Lu-177 n.c.a

 Show Specials

  • (Feb 05, 2020)

    On June 14th, 2020 at 16:30 in Isotopia booth (163#) we are launching Isotopia new product: Lu-177 n.c.a.


  • Lu-177 chloride
    Lutetium-177, half-life 6.73d, is a ß-emitter at 498 keV (78.6%) and 177 keV (12.2%) decaying into stable Hafnium- 177....

  • vghghgig
  • isoPROtrace11
    Kit for 68Ga-PSMA11 Radiolabeling...

  • isoPROtrace-11 kit for labeling with 68Ga, is a safe, useful, ready-to-use, PET CT tracer with high detectability for prostate cancer imaging and diagnosis.

    Multi-patient dose can be produced and dispensed within 5 minutes.
    The simplicity of the method is highly convenient and easy-to-integrate in any radiopharmacy.

For Technical Support with this webpage, please contact support.